Fenamax
Category:
It has anti-inflammatory, analgesic and antipyretic effects. The mechanism of action is due to the ability to inhibit the biosynthesis of prostaglandins - mediators of inflammation due to the selective inhibition of COX-2.
Compound: 1 ampoule (1.5 ml) contains active substance:
Meloxicam 15.0 mg.
The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease:
- rheumatoid arthritis;
- osteoarthritis ;
- ankylosing spondylitis (ankylosing spondylitis);
- soft tissue rheumatism;
- acute attack of gout;
- rheumatic inflammation;
- degenerative joint diseases accompanied by pain;
- painful conditions after operations, injuries, dental interventions.
Method of administration and dosage: Fenamax is prescribed to adult patients over 18 years of age. The course of treatment is 3 injections (daily or every other day). The drug is administered via deep intramuscular injection. The drug cannot be administered intravenously. The maximum recommended dose is 15 mg of meloxicam i.e. 1.5 ml of solution 1 time per day. In patients with an increased risk of side effects, treatment begins with a dose of 7.5 mg of meloxicam. The contents of the ampoules should not be mixed in the same syringe with other medications.
Call center
We are always ready to answer your calls or messages, we will be happy to cooperate with you.
Subscribe to Newsletter
